Pulmonary valve procedure to improve blood flow issues
Part of Genetic & congenital, Heart & circulation clinical trials.
This trial studies a transcatheter pulmonary valve (a valve placed through a catheter) in people whose right-sided outflow tract valve/conduit is not working well. It aims to improve blood flow and reduce pressure problems, while checking safety and results after the procedure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your weight is at least 20 kg (44 lbs).
- You have a problem valve/conduit in the pulmonary position that doctors feel needs treatment.
- Your tests show at least moderate “PR” and/or a mean RVOT pressure gradient of 35 mmHg or higher.
- You can have the procedure because your body size and anatomy fit the device route through the groin (femoral access).
- You are able to give consent (or your legal representative can).
- You must be free of key exclusions like active infection, certain blood/bleeding problems, drug use, and pregnancy/lactation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares regular monitoring (“clinical surveillance”) versus replacing the aortic valve using a minimally invasive procedure called TAVR for people with moderate aortic stenosis. It aims to see which approach better reduces symptoms or heart damage over time.
This study follows patients with severe aortic stenosis who get a new heart valve (the SAPIEN 3 Ultra RESILIA) through a less invasive procedure (TAVR). Researchers want to see how well this valve works over time using special heart ultrasound tests.
This trial studies a new “valve-in-valve” procedure to treat a failing aortic bioprosthetic valve. It may help people improve blood flow through the heart valve and reduce valve-related problems.
This study tests a new less-invasive heart valve (VenusP-Valve) for people whose own pulmonary valve is leaking severely. If you qualify, you could get the new valve without open-heart surgery.
This trial tests a new version of a heart valve (SAPIEN X4) placed without open-heart surgery. It's for people with severe aortic stenosis who have symptoms like shortness of breath or chest pain.
This study tests an early, first-use version of a new pulmonary valve device for children whose own valve is not working well. It may help improve blood flow from the heart to the lungs and aims to learn how safe and effective the valve is over time.
Hear when a new Complex Congenital Heart Defect trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.